Meditope-enabled trastuzumab
External Resource: Annotation
| Chains | Type | Family Name | Domain Identifier | Family Identifier | Provenance Source (Version) |
| D [auth E] | SCOP2B Superfamily | Immunoglobulin-binding domains-like | 8085561 | 3000399 | SCOP2B (2022-06-29) |
| C [auth H] | SCOP2B Superfamily | Bacterial immunoglobulin/albumin-binding domains | 8098332 | 3001373 | SCOP2B (2022-06-29) |
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| D [auth E] | | e4hjgE1 | A: Flavodoxin-like | X: Class I glutamine amidotransferase-like | H: Phosphofructokinase N-terminal domain | T: | F: | ECOD (20:10:01) |
| C [auth H] | | e4hjgH1 | A: Flavodoxin-like | X: Class I glutamine amidotransferase-like | H: Phosphofructokinase N-terminal domain | T: | F: | ECOD (20:10:01) |
| B | | e4hjgB1 | A: Flavodoxin-like | X: Class I glutamine amidotransferase-like | H: Phosphofructokinase N-terminal domain | T: | F: | ECOD (20:10:01) |
| A | | e4hjgA1 | A: Flavodoxin-like | X: Class I glutamine amidotransferase-like | H: Phosphofructokinase N-terminal domain | T: | F: | ECOD (20:10:01) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | INN name | VH-CH1 | Homo sapiens (human) | IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*01, IGHG1*02, IGHG1*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202609-0) |
| | INN name | L-KAPPA | Homo sapiens (human) | IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202609-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Heavy Chain | IGHV3 | - | immunoglobulin g-binding protein a | protein l fragment | SAbDab (2026-03-13) |
| | Light Chain | IGKV1 | Kappa | immunoglobulin g-binding protein a | protein l fragment | SAbDab (2026-03-13) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| D [auth E] | Protein L fragment | | - | - |
| C [auth H] | Immunoglobulin G-binding protein A | | - | - |
| Trastuzumab heavy chain | - | - | - |
| Trastuzumab light chain | - | - | - |